{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T13:57:18Z","timestamp":1793714238798,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD102337\\u201301A1"],"award-info":[{"award-number":["R01HD102337\\u201301A1"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["MB-1706\\u201327,943"],"award-info":[{"award-number":["MB-1706\\u201327,943"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.msard.2025.106854","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T01:37:22Z","timestamp":1763084242000},"page":"106854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-4463","authenticated-orcid":false,"given":"Jeeyeon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keara M.","family":"Ginell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Marecle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Wernimont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany J.","family":"Braley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn M.","family":"Ehde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin N.","family":"Alschuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora E.","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna L.","family":"Kratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2025.106854_bib0001","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.athoracsur.2015.11.024","article-title":"Adjust for multiple comparisons? It's not that simple","volume":"101","author":"Althouse","year":"2016","journal-title":"Ann. Thorac. Surg."},{"issue":"2","key":"10.1016\/j.msard.2025.106854_bib0002","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1037\/a0035919","article-title":"Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis","volume":"59","author":"Amtmann","year":"2014","journal-title":"Rehabil. Psychol."},{"key":"10.1016\/j.msard.2025.106854_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106386","article-title":"Medication use is associated with cognitive deficits in people with multiple sclerosis","volume":"97","author":"Atiyeh","year":"2025","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0004","doi-asserted-by":"crossref","first-page":"158","DOI":"10.7224\/1537-2073.2018-087","article-title":"Effect of Multiple sclerosis on daily activities, emotional well-being, and relationships: the Global vsMS Survey","volume":"22","author":"Bass","year":"2020","journal-title":"Int. J. MS. Care"},{"key":"10.1016\/j.msard.2025.106854_bib0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","article-title":"Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis","volume":"372","author":"Boeschoten","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2025.106854_bib0006","article-title":"Fatigue, tiredness, lack of energy, and sleepiness in multiple sclerosis patients referred for clinical polysomnography","volume":"2012","author":"Braley","year":"2012","journal-title":"Mult. Scler. Int."},{"issue":"2","key":"10.1016\/j.msard.2025.106854_bib0007","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5664\/jcsm.3442","article-title":"Obstructive sleep apnea and fatigue in patients with multiple sclerosis","volume":"10","author":"Braley","year":"2014","journal-title":"J. Clin. Sleep. Med."},{"issue":"11","key":"10.1016\/j.msard.2025.106854_bib0008","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","article-title":"The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005-2008","volume":"63","author":"Cella","year":"2010","journal-title":"J. Clin. Epidemiol."},{"issue":"1","key":"10.1016\/j.msard.2025.106854_bib0009","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/13524585221122207","article-title":"Polypharmacy and multiple sclerosis: a population-based study","volume":"29","author":"Chertcoff","year":"2023","journal-title":"Mult. Scler."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0010","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.msard.2012.05.002","article-title":"Cognitive impact of anticholinergic medication in MS: adding insult to injury?","volume":"1","author":"Cruce","year":"2012","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7224\/1537-2073.2017-029","article-title":"Short report: prevalence of cognitive impairment in newly diagnosed relapsing-remitting multiple sclerosis","volume":"20","author":"DiGiuseppe","year":"2018","journal-title":"Int. J. MS. Care"},{"issue":"5","key":"10.1016\/j.msard.2025.106854_bib0012","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1352458506071346","article-title":"The scope and nature of pain in persons with multiple sclerosis","volume":"12","author":"Ehde","year":"2006","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2025.106854_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103439","article-title":"The neurogenic bladder characteristics and treatment approaches in the patients with multiple sclerosis","volume":"58","author":"Erden","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.msard.2025.106854_bib0014","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","article-title":"Comorbidity is associated with pain-related activity limitations in multiple sclerosis","volume":"4","author":"Fiest","year":"2015","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"1","key":"10.1016\/j.msard.2025.106854_bib0015","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1038\/s41598-019-40283-5","article-title":"Multi-drug use among patients with multiple sclerosis: a cross-sectional study of associations to clinicodemographic factors","volume":"9","author":"Frahm","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2025.106854_bib0016","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12883-021-02344-z","article-title":"The association of selected multiple sclerosis symptoms with disability and quality of life: a large Danish self-report survey","volume":"21","author":"Gustavsen","year":"2021","journal-title":"BMC. Neurol."},{"issue":"347","key":"10.1016\/j.msard.2025.106854_bib0017","first-page":"1","article-title":"Prescription drug use among adults aged 40-79 in the United States and Canada","author":"Hales","year":"2019","journal-title":"NCHS Data Br."},{"issue":"3","key":"10.1016\/j.msard.2025.106854_bib0018","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7224\/1537-2073.2019-091","article-title":"Impact of cognitive impairment on adults with multiple sclerosis and their Family caregivers","volume":"23","author":"Halstead","year":"2021","journal-title":"Int. J. MS. Care"},{"issue":"2","key":"10.1016\/j.msard.2025.106854_bib0019","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7224\/1537-2073.2021-062","article-title":"Characteristics of prescription drug use among individuals with multiple sclerosis in the US Medicare population","volume":"24","author":"Hartung","year":"2022","journal-title":"Int. J. MS. Care"},{"issue":"6","key":"10.1016\/j.msard.2025.106854_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.conb.2006.09.002","article-title":"The role of acetylcholine in learning and memory","volume":"16","author":"Hasselmo","year":"2006","journal-title":"Curr. Opin. Neurobiol."},{"issue":"14","key":"10.1016\/j.msard.2025.106854_bib0021","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.1019128108","article-title":"Time-dependent corticosteroid modulation of prefrontal working memory processing","volume":"108","author":"Henckens","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"8","key":"10.1016\/j.msard.2025.106854_bib0022","doi-asserted-by":"crossref","first-page":"864","DOI":"10.4088\/JCP.13r08609","article-title":"Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review","volume":"75","author":"Keefe","year":"2014","journal-title":"J. Clin. Psych."},{"key":"10.1016\/j.msard.2025.106854_bib0023","doi-asserted-by":"crossref","DOI":"10.2196\/59876","article-title":"Optimizing detection and prediction of cognitive function in multiple sclerosis with ambulatory cognitive tests: protocol for the longitudinal observational CogDetect-MS study","volume":"13","author":"Kratz","year":"2024","journal-title":"JMIR. Res. Protoc."},{"issue":"9","key":"10.1016\/j.msard.2025.106854_bib0024","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1586\/ern.10.99","article-title":"Multiple sclerosis-associated fatigue","volume":"10","author":"Krupp","year":"2010","journal-title":"Expert. Rev. NeurOther"},{"key":"10.1016\/j.msard.2025.106854_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-13-37","article-title":"Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis","volume":"13","author":"Learmonth","year":"2013","journal-title":"BMC. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2025.106854_bib0026","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuron.2012.09.013","article-title":"Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders","volume":"76","author":"Lesch","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.msard.2025.106854_bib0027","article-title":"Is the long-term use of benzodiazepines associated with worse cognition performance in highly educated older adults?","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Psych."},{"issue":"11","key":"10.1016\/j.msard.2025.106854_bib0028","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1177\/13524585221088731","article-title":"A promising cognitive screener in multiple sclerosis: the NIH toolbox cognition battery concords with gold standard neuropsychological measures","volume":"28","author":"Manglani","year":"2022","journal-title":"Mult. Scler."},{"issue":"9","key":"10.1016\/j.msard.2025.106854_bib0029","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S1474-4422(05)70166-6","article-title":"Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing","volume":"4","author":"Mitchell","year":"2005","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0030","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1192\/bjp.bp.110.077503","article-title":"Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]","volume":"197","author":"Morgan","year":"2010","journal-title":"Br. J. Psych."},{"key":"10.1016\/j.msard.2025.106854_bib0031","doi-asserted-by":"crossref","unstructured":"Murphy, K.L., Bethea, J.R., & Fischer, R. (2017). Neuropathic pain in multiple sclerosis-current therapeutic intervention and future treatment perspectives. In I. S. Zagon & P. J. McLaughlin (Eds.), Multiple Sclerosis: Perspectives in Treatment and Pathogenesis. https:\/\/doi.org\/10.15586\/codon.multiplesclerosis.2017.ch4.","DOI":"10.15586\/codon.multiplesclerosis.2017.ch4"},{"key":"10.1016\/j.msard.2025.106854_bib0033","series-title":"Disease modification. Retrieved May 1st from","author":"National","year":"2025"},{"key":"10.1016\/j.msard.2025.106854_bib0032","year":"2025","journal-title":"Multiple sclerosis"},{"key":"10.1016\/j.msard.2025.106854_bib0034","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/1874205X01812010019","article-title":"Cognitive and language deficits in Multiple sclerosis: comparison of relapsing remitting and secondary progressive subtypes","volume":"12","author":"Ntoskou","year":"2018","journal-title":"Open. Neurol. J."},{"key":"10.1016\/j.msard.2025.106854_bib0035","unstructured":"Office of the Surgeon General. (2016). The neurobiology of substance use, misuse, and addiction. In Facing Addiction in America: The Surgeon General's Report On Alcohol, Drugs, and Health (pp. Chapter 2). US Department of Health and Human Services."},{"issue":"1","key":"10.1016\/j.msard.2025.106854_bib0036","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1682\/JRRD.2004.11.0148","article-title":"Cognition and fatigue in multiple sclerosis: potential effects of medications with central nervous system activity","volume":"43","author":"Oken","year":"2006","journal-title":"J. Rehabil. Res. Dev."},{"issue":"3","key":"10.1016\/j.msard.2025.106854_bib0037","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1073191111411667","article-title":"Item banks for measuring emotional distress from the Patient-Reported Outcomes Measurement Information System (PROMIS(R)): depression, anxiety, and anger","volume":"18","author":"Pilkonis","year":"2011","journal-title":"Assessment."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0038","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1097\/PR9.0000000000000669","article-title":"Effects of long-term opioid analgesics on cognitive performance and plasma cytokine concentrations in patients with chronic low back pain: a cross-sectional pilot study","volume":"3","author":"Richards","year":"2018","journal-title":"Pain. Rep."},{"issue":"2","key":"10.1016\/j.msard.2025.106854_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09084280701319938","article-title":"PASAT in detecting cognitive impairment in relapsing-remitting MS","volume":"14","author":"Rosti","year":"2007","journal-title":"Appl. Neuropsychol."},{"issue":"11","key":"10.1016\/j.msard.2025.106854_bib0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1097\/FPC.0b013e32833132cb","article-title":"Selective serotonin reuptake inhibitors pathway","volume":"19","author":"Sangkuhl","year":"2009","journal-title":"Pharmacogenet. Genom."},{"issue":"3","key":"10.1016\/j.msard.2025.106854_bib0041","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hup.1196","article-title":"A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use","volume":"26","author":"Schoedel","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.msard.2025.106854_bib0042","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S2215-0366(16)00012-2","article-title":"Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study","volume":"3","author":"Shilyansky","year":"2016","journal-title":"Lancet Psych."},{"issue":"2","key":"10.1016\/j.msard.2025.106854_bib0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40263-018-0489-5","article-title":"Depression in Multiple sclerosis: epidemiology, aetiology, diagnosis and treatment","volume":"32","author":"Solaro","year":"2018","journal-title":"CNS. Drugs"},{"issue":"3","key":"10.1016\/j.msard.2025.106854_bib0044","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/BF02245119","article-title":"Amitriptyline, clovoxamine and cognitive function: a placebo-controlled comparison in depressed outpatients","volume":"108","author":"Spring","year":"1992","journal-title":"Psychopharmacol. (Berl)"},{"issue":"3","key":"10.1016\/j.msard.2025.106854_bib0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/arclin\/13.3.259","article-title":"A review of the neuropsychological effects of commonly used prescription medications","volume":"13","author":"Stein","year":"1998","journal-title":"Arch. Clin. Neuropsychol."},{"issue":"13","key":"10.1016\/j.msard.2025.106854_bib0046","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1177\/1352458518808204","article-title":"Symbol digit modalities test: a valid clinical trial endpoint for measuring cognition in multiple sclerosis","volume":"25","author":"Strober","year":"2019","journal-title":"Mult. Scler."},{"issue":"11","key":"10.1016\/j.msard.2025.106854_bib0047","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1007\/s00415-009-5257-5","article-title":"Symptomatology of MS: results from the German MS Registry","volume":"256","author":"Stuke","year":"2009","journal-title":"J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2025.106854_bib0048","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jpsychores.2014.02.013","article-title":"Polypharmacy in multiple sclerosis: relationship with fatigue, perceived cognition, and objective cognitive performance","volume":"76","author":"Thelen","year":"2014","journal-title":"J. Psychosom. Res."},{"issue":"4","key":"10.1016\/j.msard.2025.106854_bib0049","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.jcp.0000227699.26375.f8","article-title":"Mood and neuropsychological changes in women with midlife depression treated with escitalopram","volume":"26","author":"Wroolie","year":"2006","journal-title":"J. Clin. Psychopharmacol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034825005966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:15:00Z","timestamp":1781122500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034825005966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":49,"alternative-id":["S2211034825005966"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2025.106854","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between medication use and multiple domains of cognitive function in people with multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2025.106854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106854"}}